Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week
Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week
![AWS and pharma heavyweights join forces on AI-based drug discovery lab - Drug Discovery and Development AWS and pharma heavyweights join forces on AI-based drug discovery lab - Drug Discovery and Development](https://www.drugdiscoverytrends.com/wp-content/uploads/2021/10/AION-Labs.png)